NCT03210662
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Recurrent Mature T- Cell and NK-Cell Non-Hodgkin Lymphoma
Explore clinical trials studying Recurrent Mature T- Cell and NK-Cell Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Recurrent Mature T- Cell and NK-Cell Non-Hodgkin Lymphoma trial results
Active, Not Recruiting
Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas
NCT03598998
- Conditions
- Anaplastic Large Cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, +35 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States